Channon KM - Search Results

1

Therapeutic strategies targeting endothelial function in humans: clinical implications.

Lee R, Channon KM, Antoniades C. Lee R, et al. Among authors: channon km. Curr Vasc Pharmacol. 2012 Jan;10(1):77-93. doi: 10.2174/157016112798829751. Curr Vasc Pharmacol. 2012. PMID: 22112349 Review.

2

Nitric oxide synthase in atherosclerosis and vascular injury: insights from experimental gene therapy.

Channon KM, Qian H, George SE. Channon KM, et al. Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1873-81. doi: 10.1161/01.atv.20.8.1873. Arterioscler Thromb Vasc Biol. 2000. PMID: 10938006 Review.

3

Antithrombotic strategies in gene therapy.

Channon KM, Annex BH. Channon KM, et al. Curr Cardiol Rep. 2000 Jan;2(1):34-8. doi: 10.1007/s11886-000-0023-4. Curr Cardiol Rep. 2000. PMID: 10980870 Review.

4

Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis.

Guzik TJ, Black E, West NE, McDonald D, Ratnatunga C, Pillai R, Channon KM. Guzik TJ, et al. Among authors: channon km. Am J Med Genet. 2001 Apr 22;100(2):130-7. doi: 10.1002/ajmg.1229. Am J Med Genet. 2001. PMID: 11298374

5

Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors.

Channon KM, Guzik TJ. Channon KM, et al. J Physiol Pharmacol. 2002 Dec;53(4 Pt 1):515-24. J Physiol Pharmacol. 2002. PMID: 12512689 Free article. Review.

6

Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression.

Alp NJ, Mussa S, Khoo J, Cai S, Guzik T, Jefferson A, Goh N, Rockett KA, Channon KM. Alp NJ, et al. Among authors: channon km. J Clin Invest. 2003 Sep;112(5):725-35. doi: 10.1172/JCI17786. J Clin Invest. 2003. PMID: 12952921 Free PMC article.

7

Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.

Alp NJ, Channon KM. Alp NJ, et al. Among authors: channon km. Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):413-20. doi: 10.1161/01.ATV.0000110785.96039.f6. Epub 2003 Dec 4. Arterioscler Thromb Vasc Biol. 2004. PMID: 14656731 Review.

8

Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.

Alp NJ, McAteer MA, Khoo J, Choudhury RP, Channon KM. Alp NJ, et al. Among authors: channon km. Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):445-50. doi: 10.1161/01.ATV.0000115637.48689.77. Epub 2004 Jan 5. Arterioscler Thromb Vasc Biol. 2004. PMID: 14707037

9

Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.

Schäfer A, Alp NJ, Cai S, Lygate CA, Neubauer S, Eigenthaler M, Bauersachs J, Channon KM. Schäfer A, et al. Among authors: channon km. Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1720-6. doi: 10.1161/01.ATV.0000138072.76902.dd. Epub 2004 Jul 8. Arterioscler Thromb Vasc Biol. 2004. PMID: 15242858

10

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins.

Guzik TJ, Sadowski J, Kapelak B, Jopek A, Rudzinski P, Pillai R, Korbut R, Channon KM. Guzik TJ, et al. Among authors: channon km. Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1614-20. doi: 10.1161/01.ATV.0000139011.94634.9d. Epub 2004 Jul 15. Arterioscler Thromb Vasc Biol. 2004. PMID: 15256399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters